ScoreWhy is Wuhan Hiteck Biological Pharma Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of 4.47% and Operating profit at -220.66% over the last 5 years
- NET SALES(HY) At CNY 265.23 MM has Grown at -16.88%
- OPERATING CASH FLOW(Y) Lowest at CNY -72.75 MM
- ROCE(HY) Lowest at -8.03%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 60.62%, its profits have risen by 37.9%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wuhan Hiteck Biological Pharma Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wuhan Hiteck Biological Pharma Co., Ltd.
51.1%
0.99
67.25%
China Shanghai Composite
15.17%
1.02
14.86%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.47%
EBIT Growth (5y)
-220.66%
EBIT to Interest (avg)
-56.97
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
0.25
Tax Ratio
4.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.21%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.90
EV to EBIT
-27.77
EV to EBITDA
-97.91
EV to Capital Employed
2.28
EV to Sales
5.96
PEG Ratio
NA
Dividend Yield
0.38%
ROCE (Latest)
-8.22%
ROE (Latest)
-3.73%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -2.02% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.73 times
-30What is not working for the Company
NET SALES(HY)
At CNY 265.23 MM has Grown at -16.88%
OPERATING CASH FLOW(Y)
Lowest at CNY -72.75 MM
ROCE(HY)
Lowest at -8.03%
DEBT-EQUITY RATIO
(HY)
Highest at -29.43 %
CASH AND EQV(HY)
Lowest at CNY 1,434.4 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.06 times
OPERATING PROFIT(Q)
Lowest at CNY -131.09 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -89.27 %
PRE-TAX PROFIT(Q)
Lowest at CNY -129.59 MM
NET PROFIT(Q)
Lowest at CNY -120.98 MM
EPS(Q)
Lowest at CNY -0.91
Here's what is working for Wuhan Hiteck Biological Pharma Co., Ltd.
Inventory Turnover Ratio
Highest at 3.73 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Raw Material Cost
Fallen by -2.02% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Wuhan Hiteck Biological Pharma Co., Ltd.
Pre-Tax Profit
At CNY -129.59 MM has Fallen at -463.69%
over average net sales of the previous four periods of CNY -22.99 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY -120.98 MM has Fallen at -476.87%
over average net sales of the previous four periods of CNY -20.97 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 265.23 MM has Grown at -16.88%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Debt-Equity Ratio
Highest at -29.43 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Cash Flow
Lowest at CNY -72.75 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Operating Profit
Lowest at CNY -131.09 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at -89.27 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY -129.59 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Net Profit
Lowest at CNY -120.98 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
EPS
Lowest at CNY -0.91
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (CNY)
Cash and Eqv
Lowest at CNY 1,434.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 2.06 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
